Cite
HARVARD Citation
Horibe, K. et al. (2022). Metabolic changes induced by dapagliflozin, an SGLT2 inhibitor, in Japanese patients with type 2 diabetes treated by oral anti-diabetic agents: A randomized, clinical trial. Diabetes research and clinical practice. p. . [Online].